BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Deng X, Bi Q, Chen S, Chen X, Li S, Zhong Z, Guo W, Li X, Deng Y, Yang Y. Identification of a Five-Autophagy-Related-lncRNA Signature as a Novel Prognostic Biomarker for Hepatocellular Carcinoma. Front Mol Biosci 2020;7:611626. [PMID: 33505990 DOI: 10.3389/fmolb.2020.611626] [Cited by in Crossref: 2] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang Q, Huang Y, Xia Y, Liu Y, Gan J. Cuproptosis-related lncRNAs predict the prognosis and immune response in hepatocellular carcinoma. Clin Exp Med. [DOI: 10.1007/s10238-022-00892-3] [Reference Citation Analysis]
2 Wang T, Zhou Z, Wang X, You L, Li W, Zheng C, Zhang J, Wang L, Kong X, Gao Y, Sun X. Comprehensive analysis of nine m7G-related lncRNAs as prognosis factors in tumor immune microenvironment of hepatocellular carcinoma and experimental validation. Front Genet 2022;13:929035. [DOI: 10.3389/fgene.2022.929035] [Reference Citation Analysis]
3 Su D, Zhang Z, Xu Z, Xia F, Yan Y. A prognostic exosome-related LncRNA risk model correlates with the immune microenvironment in liver cancer. Front Genet 2022;13:965329. [DOI: 10.3389/fgene.2022.965329] [Reference Citation Analysis]
4 Li S, Yao W, Liu R, Gao L, Lu Y, Zhang H, Liang X. Long non-coding RNA LINC00152 in cancer: Roles, mechanisms, and chemotherapy and radiotherapy resistance. Front Oncol 2022;12:960193. [DOI: 10.3389/fonc.2022.960193] [Reference Citation Analysis]
5 Wang W, Ye Y, Zhang X, Ye X, Liu C, Bao L. Construction of a Necroptosis-Associated Long Non-Coding RNA Signature to Predict Prognosis and Immune Response in Hepatocellular Carcinoma. Front Mol Biosci 2022;9:937979. [DOI: 10.3389/fmolb.2022.937979] [Reference Citation Analysis]
6 Chen X, Ye Q, Chen Z, Lin Q, Chen W, Xie C, Wang X. Long non-coding RNA muskelin 1 antisense RNA as a potential therapeutic target in hepatocellular carcinoma treatment. Bioengineered 2022;13:12237-47. [PMID: 35579449 DOI: 10.1080/21655979.2022.2074703] [Reference Citation Analysis]
7 Liu ZK, Wu KF, Zhang RY, Kong LM, Shang RZ, Lv JJ, Li C, Lu M, Yong YL, Zhang C, Zheng NS, Li YH, Chen ZN, Bian H, Wei D. Pyroptosis-Related LncRNA Signature Predicts Prognosis and Is Associated With Immune Infiltration in Hepatocellular Carcinoma. Front Oncol 2022;12:794034. [PMID: 35311105 DOI: 10.3389/fonc.2022.794034] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
8 Zhang Z, Zhang W, Wang Y, Wan T, Hu B, Li C, Ge X, Lu S. Construction and Validation of a Ferroptosis-Related lncRNA Signature as a Novel Biomarker for Prognosis, Immunotherapy and Targeted Therapy in Hepatocellular Carcinoma. Front Cell Dev Biol 2022;10:792676. [PMID: 35295858 DOI: 10.3389/fcell.2022.792676] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
9 Zhu XL, Li Q, Shen J, Shan L, Zuo ED, Cheng X. Use of 6 m6A-relevant lncRNA genes as prognostic markers of primary liver hepatocellular carcinoma based on TCGA database. Transl Cancer Res 2021;10:5337-51. [PMID: 35116381 DOI: 10.21037/tcr-21-2440] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
10 Pan G, Zhang J, You F, Cui T, Luo P, Wang S, Li X, Yuan Q. ETS Proto-Oncogene 1-activated muskelin 1 antisense RNA drives the malignant progression of hepatocellular carcinoma by targeting miR-22-3p to upregulate ETS Proto-Oncogene 1. Bioengineered 2022;13:1346-58. [PMID: 34983308 DOI: 10.1080/21655979.2021.2017565] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
11 Wang Y, Ge F, Sharma A, Rudan O, Setiawan MF, Gonzalez-Carmona MA, Kornek MT, Strassburg CP, Schmid M, Schmidt-Wolf IGH. Immunoautophagy-Related Long Noncoding RNA (IAR-lncRNA) Signature Predicts Survival in Hepatocellular Carcinoma. Biology (Basel) 2021;10:1301. [PMID: 34943216 DOI: 10.3390/biology10121301] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
12 Tang X, Miao Y, Wang J, Cai T, Yang L, Mi D. Identification of Mutator-Derived lncRNA Signatures of Genomic Instability for Promoting the Clinical Outcome in Hepatocellular Carcinoma. Comput Math Methods Med 2021;2021:1205029. [PMID: 34840594 DOI: 10.1155/2021/1205029] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
13 Shi X, Liu X, Pan S, Ke Y, Li Y, Guo W, Wang Y, Ruan Q, Zhang X, Ma H. A Novel Autophagy-Related Long Non-Coding RNA Signature to Predict Prognosis and Therapeutic Response in Esophageal Squamous Cell Carcinoma. Int J Gen Med 2021;14:8325-39. [PMID: 34815705 DOI: 10.2147/IJGM.S333697] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
14 Zhang H, Sun L, Hu X. Macrophages M1-Related Prognostic Signature in Hepatocellular Carcinoma. J Oncol 2021;2021:6347592. [PMID: 34745260 DOI: 10.1155/2021/6347592] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Fu Y, Wei X, Han Q, Le J, Ma Y, Lin X, Xu Y, Liu N, Wang X, Kong X, Gu J, Tong Y, Wu H. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma. BMC Cancer 2021;21:1165. [PMID: 34717566 DOI: 10.1186/s12885-021-08827-z] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
16 Feng Y, Hu X, Ma K, Zhang B, Sun C. Genome-Wide Screening Identifies Prognostic Long Noncoding RNAs in Hepatocellular Carcinoma. Biomed Res Int 2021;2021:6640652. [PMID: 34095306 DOI: 10.1155/2021/6640652] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
17 Yang S, Zhou Y, Zhang X, Wang L, Fu J, Zhao X, Yang L. The prognostic value of an autophagy-related lncRNA signature in hepatocellular carcinoma. BMC Bioinformatics 2021;22:217. [PMID: 33910497 DOI: 10.1186/s12859-021-04123-6] [Cited by in F6Publishing: 6] [Reference Citation Analysis]